FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancer

AIM: To evaluate the efficacy and safety of the modified FOLFIRI3-aflibercept as second-line therapy in patients with metastatic colorectal cancer. METHODS: This is a retrospective multicenter cohort, evaluating the efficacy and safety of the association of aflibercept with FOLFIRI3 (day 1: afliberc...

Descripción completa

Detalles Bibliográficos
Autores principales: Carola, Candice, Ghiringhelli, François, Kim, Stefano, André, Thierry, Barlet, Juliette, Bengrine-Lefevre, Leïla, Marijon, Hélène, Garcia-Larnicol, Marie-Line, Borg, Christophe, Dainese, Linda, Steuer, Nils, Richa, Hubert, Benetkiewicz, Magdalena, Larsen, Annette K, de Gramont, Aimery, Chibaudel, Benoist
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153125/
https://www.ncbi.nlm.nih.gov/pubmed/30254966
http://dx.doi.org/10.5306/wjco.v9.i5.110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153125/
https://www.ncbi.nlm.nih.gov/pubmed/30254966
http://dx.doi.org/10.5306/wjco.v9.i5.110

Ejemplares similares